The Genetics of the 16p13.3 Deletion

Understanding the biology of TSC2/PKD1 contiguous gene deletion syndrome begins with a map of chromosome 16. On the “short arm” of this chromosome, at a location known as 16p13.3, two critical genes sit side-by-side: TSC2 and PKD1 ^[1][2]. In this syndrome, a single event causes a “deletion”—a missing piece of genetic material—that spans across both of these neighboring genes ^[1].

Reduced Gene Dosage: Losing One Copy

We typically inherit two copies of every gene—one from each parent. Every gene provides instructions for making specific proteins that perform vital jobs. When a deletion occurs at 16p13.3, the body loses one copy of the instructions for two essential proteins simultaneously (this is called “reduced gene dosage” or “haploinsufficiency”):

1. Tuberin (from the TSC2 gene): Tuberin normally acts like a brake on a growth-promoting pathway called mTORC1 ^[3][4]. When one copy of the TSC2 gene is missing, this brake is impaired, and cells can grow abnormally, leading to the hamartomas (benign tumors) and brain lesions characteristic of Tuberous Sclerosis Complex (TSC) ^[4]. These are benign lesions, not cancer, but they can still impair organ function.
2. Polycystin-1 (from the PKD1 gene): This protein is crucial for the health of the tiny tubes in the kidneys. It helps maintain the normal structure of these tubes; with reduced levels, the tubes can expand into fluid-filled sacs called cysts ^[5][1].

Why the Kidney Symptoms Are More Severe

You may have heard that kidney cysts can occur in typical TSC, but the phenotype in this deletion syndrome is significantly more pronounced ^[6]. This happens because of a combined impact:

• Combined Impact: In typical TSC, cysts are usually small and few because both copies of the PKD1 gene are still working normally ^[6]. In this syndrome, the kidneys experience the loss of one copy of the structural polycystin-1 protein combined with the altered growth signaling from the missing TSC2 gene ^[5].
• Biological Interaction: Current biological models suggest that when the TSC2 “brake” is impaired, the altered growth signals may further reduce the body’s ability to use the remaining polycystin-1 ^[5]. This causes cysts to appear much earlier in life—often in infancy—and grow much larger than they would in either condition alone ^[7][6].

Diagnosis and Distinctions

Doctors distinguish this syndrome from “standard” TSC or isolated Polycystic Kidney Disease (ADPKD) by looking at the type of genetic error:

• Isolated TSC: Usually caused by a small “spelling error” (mutation) in just the TSC1 or TSC2 gene ^[2].
• Isolated ADPKD: Usually caused by a mutation in just the PKD1 or PKD2 gene ^[8].
• Contiguous Gene Deletion Syndrome: Confirmed when genetic testing shows a large copy-number loss that physically spans across the boundary of both TSC2 and PKD1 ^[2][7].

To confirm this, doctors typically use specialized tests like a chromosomal microarray (CMA) or MLPA (Multiplex Ligation-dependent Probe Amplification), which are designed to count the number of gene copies rather than just reading the DNA sequence ^[9][10]. It is important to know that this deletion is genetic and not caused by anything a parent did.

Variability and Inheritance

While every person with this syndrome has a deletion in this specific area, the “size” of the missing piece can vary. Some deletions are small and only involve parts of the two genes, while others are large (over 800 kb) and may include up to 13 or more additional genes ^[11][9]. Interestingly, having a larger deletion that involves more genes does not always mean the symptoms will be more severe; the relationship between the exact size of the deletion and how a person feels is still being studied ^[7][11].

In many cases, the deletion is de novo, meaning it happened for the first time in the child and was not passed down from a parent ^[2]. If both parents test negative for the deletion in their blood, the chance of it happening again in a future pregnancy is low, but not exactly zero due to a phenomenon called “germline mosaicism” (where only some reproductive cells carry the deletion).

However, it can also be inherited in an autosomal dominant pattern. If a parent is confirmed to carry the deletion, they have a 50% chance of passing it to their child with each pregnancy ^[12][13]. A parent carrying the deletion may only have subtle or adult-onset symptoms themselves. Formal genetic counseling is highly recommended to understand recurrence risks, explore reproductive options, and ensure parents receive appropriate screening ^[14][13].